{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:56:28Z","timestamp":1781661388852,"version":"3.54.5"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260140-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Patient-directed discharge (PDD), when patients leave the hospital prior to completing recommended medical treatment, is associated with increased morbidity and mortality and occurs in 10% to 20% of hospitalizations for patients with opioid use disorder (OUD). Understanding risk factors associated with PDD is essential to improving outcomes for this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260140-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate whether hospitalized patients with OUD who received higher doses of methadone during the first 24, 48, and 72 hours after first contact with the emergency department had decreased odds of PDD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260140-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective observational cohort study was conducted at a single academic health center in the northeastern US during the fentanyl era (July 1, 2019, to June 30, 2022). Hospitalized adults with OUD and without methadone listed in their medication history who received methadone during the first 72 hours were included. Data were analyzed from April 2025 through February 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260140-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Cumulative dose of methadone received for patients 24, 48, and 72 hours after initial evaluation in the emergency department.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260140-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>PDD by 48, 72, or 96 hours or ever, as indicated by discharge disposition in the patient electronic health record.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260140-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 554 patients were included in the study. For analysis, participants were separated into cohorts based on cumulative dose by 24 hours (325 patients), 48 hours (488 patients), and 72 hours (454 patients) after presentation to the emergency department, with the main analysis among patients in the 24-hour cohort. Among 325 patients (184 male [56.6%]; median [IQR] age, 49.0 [36.0-59.0] years) receiving methadone within 24 hours of presentation to the emergency department, the incidence of PDD was 45 patients (13.8%). In an adjusted logistic regression model, each additional 10 mg of methadone in the first 24 hours was associated with lower odds of PDD (adjusted odds ratio [aOR], 0.71; 95% CI, 0.44-0.98) at 48 hours. Results were similar for PDD at 72 hours (aOR, 0.68; 95% CI, 0.50-0.85), 96 hours (aOR, 0.72; 95% CI, 0.56-0.88), or ever (aOR, 0.79; 95% CI, 0.67-0.91) in the 24-hour cohort and qualitatively similar but with smaller decreases in odds or nonsignificant outcomes for cumulative methadone dose in the 48-hour cohort (eg, PDD at 96 hours: aOR, 0.91; 95% CI, 0.82-0.99) and nonsignificant outcomes in the 72-hour cohort (eg, PDD at 96 hours: aOR, 0.98; 95% CI, 0.89-1.06).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260140-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study, higher cumulative doses of methadone during the first 48 hours of care were associated with substantial reductions in the incidence of PDD. These findings suggest that early and adequate treatment of withdrawal with methadone may be associated with reduced PDD among hospitalized patients with OUD in the fentanyl era.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.3439","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:30:41Z","timestamp":1774452641000},"page":"e263439","source":"Crossref","is-referenced-by-count":3,"title":["Methadone Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder"],"prefix":"10.1001","volume":"9","author":[{"given":"Rebecca R.","family":"Meredith","sequence":"first","affiliation":[{"name":"Division of Hospital Medicine, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Garneau","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Feder","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Buresh","sequence":"additional","affiliation":[{"name":"Division of Addiction Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"3","key":"zoi260140r2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"8","key":"zoi260140r3","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s11606-020-05815-0","article-title":"Opioid agonist therapy during hospitalization within the Veterans Health Administration: a pragmatic retrospective cohort analysis.","volume":"35","author":"Priest","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"8","key":"zoi260140r4","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1111\/add.15393","article-title":"Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014-18.","volume":"116","author":"Jo","year":"2021","journal-title":"Addiction"},{"issue":"23","key":"zoi260140r5","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1001\/jama.2023.21288","article-title":"Trends in before medically advised discharges for patients with opioid use disorder, 2016-2020.","volume":"330","author":"Thakrar","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"zoi260140r6","doi-asserted-by":"publisher","first-page":"e2484","DOI":"10.1093\/cid\/ciaa1126","article-title":"Against medical advice discharges in injection and non-injection drug use-associated infective endocarditis: a nationwide cohort study.","volume":"73","author":"Kimmel","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"12","key":"zoi260140r7","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.2105\/AJPH.2015.302885","article-title":"Leaving the hospital against medical advice among people who use illicit drugs: a systematic review.","volume":"105","author":"Ti","year":"2015","journal-title":"Am J Public Health"},{"issue":"6","key":"zoi260140r8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.amjmed.2011.12.017","article-title":"Increased risk of mortality and readmission among patients discharged against medical advice.","volume":"125","author":"Southern","year":"2012","journal-title":"Am J Med"},{"issue":"4","key":"zoi260140r9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","article-title":"Understanding why patients with substance use disorders leave the hospital against medical advice: a qualitative study.","volume":"41","author":"Simon","year":"2020","journal-title":"Subst Abus"},{"issue":"1","key":"zoi260140r10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/ADM.0000000000000823","article-title":"Polysubstance overdose deaths in the fentanyl era: a latent class analysis.","volume":"16","author":"Park","year":"2022","journal-title":"J Addict Med"},{"issue":"9","key":"zoi260140r11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.35895","article-title":"Buprenorphine-precipitated withdrawal among hospitalized patients using fentanyl.","volume":"7","author":"Thakrar","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi260140r12","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s11606-023-08059-w","article-title":"Association of early opioid withdrawal treatment strategy and patient-directed discharge among hospitalized patients with opioid use disorder.","volume":"38","author":"Alrawashdeh","year":"2023","journal-title":"J Gen Intern Med"},{"key":"zoi260140r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209004","article-title":"Safety of rapid inpatient methadone initiation protocol: a retrospective cohort study.","volume":"148","author":"Racha","year":"2023","journal-title":"J Subst Use Addict Treat"},{"issue":"3","key":"zoi260140r14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/08897077231185655","article-title":"Rapid methadone induction in a general hospital setting: a retrospective, observational analysis.","volume":"44","author":"Casey","year":"2023","journal-title":"Subst Abus"},{"issue":"1","key":"zoi260140r15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13722-023-00368-z","article-title":"Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder.","volume":"18","author":"Thakrar","year":"2023","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"zoi260140r16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/ADM.0000000000001324","article-title":"Piloting a hospital-based rapid methadone initiation protocol for fentanyl.","volume":"18","author":"Liu","year":"2024","journal-title":"J Addict Med"},{"issue":"1","key":"zoi260140r17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/ADM.0000000000000688","article-title":"Discharges \u201cagainst medical advice\u201d in patients with opioid-related hospitalizations.","volume":"15","author":"Santos","year":"2021","journal-title":"J Addict Med"},{"key":"zoi260140r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100066","article-title":"Methadone treatment and patient-directed hospital discharges among patients with opioid use disorder: observations from general medicine services at an urban, safety-net hospital.","volume":"3","author":"Tierney","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"issue":"6","key":"zoi260140r19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamainternmed.2024.8586","article-title":"Hospital addiction consultation service and opioid use disorder treatment: the START randomized clinical trial.","volume":"185","author":"Ober","year":"2025","journal-title":"JAMA Intern Med"},{"key":"zoi260140r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100219","article-title":"Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016-2019.","volume":"10","author":"Shearer","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"issue":"2","key":"zoi260140r23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/ADM.0000000000000725","article-title":"Medications for opioid use disorder associated with less against medical advice discharge among persons who inject drugs hospitalized with an invasive infection.","volume":"15","author":"Nolan","year":"2021","journal-title":"J Addict Med"},{"issue":"11","key":"zoi260140r24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.amjmed.2020.04.025","article-title":"Effect of inpatient medication-assisted therapy on against-medical-advice discharge and readmission rates.","volume":"133","author":"Wang","year":"2020","journal-title":"Am J Med"},{"issue":"1","key":"zoi260140r25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00126334-200401010-00008","article-title":"HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support.","volume":"35","author":"Chan","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"zoi260140r26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/add.13214","article-title":"Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.","volume":"111","author":"McNeil","year":"2016","journal-title":"Addiction"},{"key":"zoi260140r28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajem.2024.08.036","article-title":"Tranq dope: characterization of an ED cohort treated with a novel opioid withdrawal protocol in the era of fentanyl\/xylazine.","volume":"85","author":"London","year":"2024","journal-title":"Am J Emerg Med"},{"issue":"3","key":"zoi260140r29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence.","author":"Faggiano","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"zoi260140r30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders.","volume":"375","author":"Schuckit","year":"2016","journal-title":"N Engl J Med"},{"issue":"13","key":"zoi260140r31","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1007\/s11606-024-09341-1","article-title":"Early results of implementing rapid methadone titration for hospitalized patients: a case series.","volume":"40","author":"Martin","year":"2025","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi260140r32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s40001-023-01538-0","article-title":"Initiation and rapid titration of methadone and slow-release oral morphine (SROM) in an acute care, inpatient setting: a case series.","volume":"28","author":"Rodger","year":"2023","journal-title":"Eur J Med Res"},{"issue":"6","key":"zoi260140r33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/ADM.0000000000001207","article-title":"Safety and efficacy of rapid methadone titration for opioid use disorder in an inpatient setting: a retrospective cohort study.","volume":"17","author":"Klaire","year":"2023","journal-title":"J Addict Med"},{"issue":"11","key":"zoi260140r34","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/jhm.13138","article-title":"Things we do for no reason: avoiding methadone for opioid withdrawal.","volume":"18","author":"Martin","year":"2023","journal-title":"J Hosp Med"},{"issue":"7","key":"zoi260140r35","doi-asserted-by":"publisher","first-page":"e1649","DOI":"10.1093\/cid\/ciaa1278","article-title":"Evaluating differences in opioid and stimulant use-associated infectious disease hospitalizations in Florida, 2016-2017.","volume":"73","author":"Serota","year":"2021","journal-title":"Clin Infect Dis"},{"key":"zoi260140r1","volume-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Owens","year":"2006"},{"key":"zoi260140r21","unstructured":"Microsoft Corporation. Excel 365. Accessed February 11, 2026. https:\/\/www.microsoft.com\/en-us\/microsoft-365\/excel"},{"key":"zoi260140r22","unstructured":"R Foundation. The R project for statistical computing. Accessed February 11, 2026. https:\/\/www.r-project.org\/"},{"key":"zoi260140r27","unstructured":"Maryland Department of Health. Unintentional drug- and alcohol-related intoxication deaths in Maryland, 2023. 2025. Accessed January 16, 2026. https:\/\/health.maryland.gov\/vsa\/Documents\/Overdose\/2023_IntoxAnnualReport_Final.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846939\/meredith_2026_oi_260140_1773848825.51846.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:30:44Z","timestamp":1774452644000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.3439","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]}}}